Ziresovir reduces the severity of respiratory syncytial virus in hospitalized infants
1. Ziresovir, an antiviral drug targeted at respiratory syncytial virus (RSV), was superior to placebo in reducing signs and symptoms ...
Tag: respiratory syncytial virus
#VisualAbstract: Ziresovir Reduces Signs and Symptoms in Hospitalized Infants with Respiratory Syncytial Virus Infection
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
#VisualAbstract: Nirsevimab Reduces Hospitalization for RSV Bronchiolitis
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
RSVpreF vaccine prevents RSV-associated illness in adults aged 60+
1. In this randomized controlled trial, respiratory syncytial virus prefusion F protein-based vaccine (RSVpreF) prevented RSV-associated lower respiratory tract illness ...
RSVpreF vaccine prevents severe RSV-associated illness in infants
1. In this randomized controlled trial, respiratory syncytial virus prefusion F protein−based vaccine (RSVpreF) administered during pregnancy prevented severe RSV ...
![RSV positivity associated with reduced serious bacterial infection risk [Classics Series]](https://www.2minutemedicine.com/wp-content/uploads/2013/09/800px-Respiratory_syncytial_virus_01-350x250.jpg)
RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection
1. In this phase 2a study, the RSVpreF vaccine was effective against symptomatic respiratory syncytial virus (RSV) infection as compared ...
Patient Basics: Respiratory Syncytial Virus
Originally published by Harvard Health. What Is It? Respiratory syncytial virus (RSV) is one of the many viruses that cause ...
RSV positivity associated with reduced serious bacterial infection risk [Classics Series]
Image: PD 1. RSV-positive infants were significantly less likely to have an SBI than those who tested negative (7% vs. ...